The Science of Sustainable Weight Loss
FDA-approved GLP-1 therapy (semaglutide) with physician supervision — proven to produce 15–20% body weight reduction in clinical trials.
What Is Medicated Weight Loss?
Medicated weight loss at LifeBoost MD centers on semaglutide — a GLP-1 receptor agonist originally developed for type 2 diabetes that has proven to be a landmark advance in obesity medicine. Semaglutide (brand names Ozempic and Wegovy) works by mimicking the GLP-1 hormone naturally released after eating, signaling the brain to reduce appetite, slow gastric emptying, and improve insulin sensitivity. Clinical trials (STEP trials) demonstrate average weight loss of 15–17% of body weight over 68 weeks — with some patients losing over 20%. At LifeBoost MD, Dr. Stratt provides medically supervised semaglutide programs that include comprehensive metabolic evaluation, individualized dosing, and ongoing monitoring to maximize results and safety.
Key Benefits
Clinically Proven 15–20% Body Weight Reduction
The STEP trials demonstrate unprecedented weight loss outcomes — an average of 15% body weight lost over 68 weeks, with some participants losing 20%+.
Dramatically Reduces Appetite
Semaglutide signals the hypothalamus to reduce hunger, making it dramatically easier to maintain a caloric deficit without willpower battles.
Improves Metabolic Health
Beyond weight loss, semaglutide improves insulin sensitivity, lowers blood pressure, and reduces cardiovascular risk markers.
Physician-Supervised Safety
Dr. Stratt monitors your response, manages any side effects, and adjusts your protocol to ensure consistent progress without compromising health.
Sustainable, Long-Term Results
Unlike crash diets, GLP-1 therapy resets your metabolic set point and hunger signaling — making it easier to maintain weight loss over time.
Complements Hormonal Optimization
Hormonal imbalances (especially low testosterone in men and estrogen dysregulation in women) impair weight loss. Pairing semaglutide with BHRT dramatically enhances outcomes.
Conditions We Treat
Who Is This Treatment For?
- Adults with a BMI of 30 or higher (obesity)
- Adults with BMI 27+ and at least one weight-related health condition
- Patients who have struggled to lose weight with diet and exercise alone
- Individuals with insulin resistance or pre-diabetes seeking metabolic improvement
- Patients who want physician supervision and a science-based approach
- Those seeking weight loss in conjunction with hormone optimization
What to Expect
- 1
Metabolic Consultation
Dr. Stratt reviews your weight history, diet, activity level, previous weight loss attempts, medications, and medical history to confirm candidacy.
- 2
Comprehensive Lab Work
Bloodwork includes HbA1c, fasting glucose, insulin, lipid panel, thyroid, liver enzymes, and a complete metabolic panel to baseline your metabolic health.
- 3
Starting Dose & Titration Plan
Semaglutide begins at a low dose (0.25 mg/week) to minimize side effects, with a structured 4–8 week titration schedule to the therapeutic dose (1–2.4 mg/week).
- 4
Monthly Check-Ins
Regular monitoring of weight, blood pressure, lab values, and side effects. Dosing is adjusted based on your response and tolerability.
- 5
Long-Term Maintenance Planning
As you approach your goal weight, Dr. Stratt develops a sustainable maintenance strategy — which may include continued lower-dose semaglutide, dietary counseling, and metabolic optimization.
Results Timeline
Most patients lose 3–5 pounds in the first month as appetite suppression takes effect. Significant weight loss (8–15+ lbs) is typically visible by month 2–3. The average patient loses 15% of body weight at 6–9 months. Weight continues to decrease toward the full 17–20% range with consistent adherence at 12–18 months.
Frequently Asked Questions
Yes — semaglutide is the active ingredient in both Ozempic (FDA-approved for type 2 diabetes, 0.5–2 mg/week) and Wegovy (FDA-approved for weight management, up to 2.4 mg/week). At LifeBoost MD, Dr. Stratt prescribes semaglutide based on your clinical needs and goals.
The most common side effects are gastrointestinal: nausea, vomiting, diarrhea, and constipation — especially during dose escalation. These are typically mild-to-moderate and improve significantly as your body adjusts. Starting at a low dose and titrating slowly (as we do at LifeBoost) minimizes these effects considerably.
Semaglutide treats the underlying biology of obesity — which is a chronic condition. Clinical trials show that patients who discontinue semaglutide regain a significant portion of their weight within a year. Long-term, low-dose maintenance therapy may be appropriate for many patients, similar to how antihypertensive medications are used long-term for blood pressure.
Yes — and this combination is highly synergistic. Hormonal imbalances are major drivers of weight gain and metabolic dysfunction. Optimizing testosterone (men) or estrogen/progesterone (women) alongside semaglutide dramatically improves both weight loss outcomes and overall metabolic health.
Significantly. Online programs may prescribe semaglutide without thorough metabolic workup, monitoring, or access to a physician for side effect management. At LifeBoost MD, Dr. Stratt personally oversees every aspect of your program, integrates your weight loss with your complete health picture, and is accessible for any concerns throughout your journey.
Medical References & Citations
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384:989-1002.
- Rubino DM, et al. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity. JAMA. 2021.
- Marso SP, et al. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med. 2016.